Who
John C. Fortson
EVP & CFO
Company insider
Files Form 4 as: EVP & CFO, Dentsply Sirona; President & CEO, Ingevity; VP, CFO & Treasurer, Aar.
In numbers
- Trades disclosed
- 68
- Buys
- 1
- Sells
- 1
- Bought
- $150K
- Sold
- $2.1M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 14 Jul 2014
- Last trade
- 10 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 12 Aug 2026 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Code A | —24,014 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | XRAY Dentsply Sironaoption or derivative · Medical Devices | SEC FORM 4 Code A | —104,200 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | XRAY Dentsply Sironaoption or derivative · Medical Devices | SEC FORM 4 Code A | —104,200 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Code A | —24,014 at $0.00 | filing |
| 28 Feb 2024filed 1 Mar 2024 | NGVT IngevityChemicals | SEC FORM 4 Code F | $72K1,597 at $45.27 | filing |
| 28 Feb 2024filed 1 Mar 2024 | NGVT IngevityChemicals | SEC FORM 4 Code F | $136K2,995 at $45.27 | filing |
| 28 Feb 2024filed 1 Mar 2024 | NGVT IngevityChemicals | SEC FORM 4 Code A | —35,344 at $0.00 | filing |
| 28 Feb 2024filed 1 Mar 2024 | NGVT IngevityChemicals | SEC FORM 4 Code A | —15,107 at $0.00 | filing |
| 26 Feb 2024filed 28 Feb 2024 | NGVT IngevityChemicals | SEC FORM 4 Code F | $66K1,377 at $48.11 | filing |
| 22 Feb 2024filed 26 Feb 2024 | NGVT IngevityChemicals | SEC FORM 4 Code A | —11,934 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | NGVT IngevityChemicals | SEC FORM 4 Code F | $262K5,527 at $47.40 | filing |
| 28 Feb 2023filed 1 Mar 2023 | NGVT IngevityChemicals | SEC FORM 4 Code F | $66K803 at $82.56 | filing |
| 28 Feb 2023filed 1 Mar 2023 | NGVT IngevityChemicals | SEC FORM 4 Code F | $132K1,597 at $82.56 | filing |
| 28 Feb 2023filed 1 Mar 2023 | NGVT IngevityChemicals | SEC FORM 4 Code A | —19,380 at $0.00 | filing |
| 27 Feb 2023filed 1 Mar 2023 | NGVT IngevityChemicals | SEC FORM 4 Code F | $121K1,376 at $87.81 | filing |
| 16 Feb 2023filed 21 Feb 2023 | NGVT IngevityChemicals | SEC FORM 4 Code A | —8,835 at $0.00 | filing |
| 16 Feb 2023filed 21 Feb 2023 | NGVT IngevityChemicals | SEC FORM 4 Code F | $252K2,810 at $89.67 | filing |
| 16 Feb 2023filed 21 Feb 2023 | NGVT IngevityChemicals | SEC FORM 4 Code A | —10,430 at $0.00 | filing |
| 16 Feb 2023filed 21 Feb 2023 | NGVT IngevityChemicals | SEC FORM 4 Code F | $293K3,270 at $89.67 | filing |
| 28 Feb 2022filed 2 Mar 2022 | NGVT Ingevityoption or derivative · Chemicals | SEC FORM 4 Code A | —25,278 at $0.00 | filing |
News
Head to Head Contrast: Mosaic (NYSE:MOS) versus Ingevity (NYSE:NGVT)NGVT · tickerreport.com · 22 Oct 2026
0 headlines in the last 90 days name John C. Fortson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.